<sentence id="0">Binding of erythroid and non-erythroid nuclear proteins to the silencer of the human epsilon-globin-encoding gene .</sentence>
<sentence id="1">To clarify the molecular mechanisms involved in the developmental control of hemoglobin-encoding genes we have been studying the expression of these genes in human cells in continuous culture .</sentence>
<sentence id="2">We have previously reported the presence of a transcriptional control element with the properties of a silencer extending from -392 to -177 bp relative to the cap site of the human epsilon-globin-encoding gene [ Cao et al. , Proc.Natl.Acad.Sci.USA 86 ( 1989 ) 5306-5309 ] .</sentence>
<sentence id="3">We also showed that this silencer has stronger inhibitory activity in HeLa cells , as compared to K562 human erythroleukemia cells .</sentence>
<sentence id="4">Using deletion mutants and cis-cloned synthetic oligodeoxyribonucleotides in transient expression assays , nucleotide sequences responsible for this effect have now been further delimited to 44 bp located from -294 to -251 bp .</sentence>
<sentence id="5">Gel electrophoresis mobility shift assays and DNaseI footprinting assays demonstrate that these negative regulatory sequences are recognized differently by proteins present in nuclear extracts obtained from HeLa and K562 cells .</sentence>
<sentence id="6"><scope type="spec" id="0"> <cue type="spec" id="0">Two</cue> binding proteins are detected in K562 nuclear extracts</scope> , while only one is found in extracts from HeLa cells .</sentence>
<sentence id="7">Possible mechanisms by which these proteins <scope type="spec" id="1"> <cue type="spec" id="1">may</cue> regulate transcription of the epsilon-globin-encoding gene in erythroid and non-erythroid cells</scope> are discussed .</sentence>